Chromatin

Editor: Paul S. Knoepfler, Ph.D.

 

Home

Chromatin Basics

Tools

Protocols

Chromatin Blog

Hot Papers 2010

Chromatin Links

Editor

Fun Links

Chromatin Blog
Admin Login
The epigenome dwarfs the genome in complexity
By Stem Cell Blogger | April 16, 2010 at 05:04 PM EDT | No Comments

What if we really could take a snapshot of a cell's epigenome? I think it would tell us an enormous amount of the identity of the cell and what makes it tick. However, the epigenome is many orders of magnitude more complex than the genome. Also, while the genome is fairly static, the epigenome is inherently dynamic, constantly visited by trillions of molecules of likely 100s of types of enzymes that tinker with it. 


So if one is look for a cancer-causing mutation in the genome, it may be a challenge to find it but it is doable. But if one is looking cancer-causing epi-mutations, it is much more difficult.  There are likely suspects already including specific modifications of lysine residues in histones and certain spots of DNA methylation, but the complexity of the epigenome means that not only every cancer type, but every cancer cell has its own epigenomic signature consisting of a mindboggling combination of different possible histone modifications and DNA methylation events. No, it can't be that complex you say? Well, how many possible combinations of histone and DNA modifications are possible within an octamer of a single nucleosome?  It's got to be hundreds or thousands. 

So what to do?  The current approach of looking for defining events that fairly consistently show up in say cancer cells versus normal cells is working, but is too slow. We need new more powerful technology to "sequence" the epigenome....I don't know what that technology will be but current methods such as ChIP-Seq, while really revolutionary, still cannot handle the complexity of the epigenome. 

HDACi for iPS cells and cancer therapy
By Stem Cell Blogger | March 17, 2010 at 05:15 PM EDT | No Comments

A commenter asked about what HDACi would have anti tumor activity. It's a good question and I also wanted to point out that HDACi enhance iPS cell formation, presumably through chromatin reprogramming. So one question is whether the mechanism by which HDACi inhibit tumors is related to the mechanism by which they enhance iPS formation. I think most likely the answer is "no", but at this point we don't know. Some have speculated that HDACi re-activate silenced tumor suppressors to target cancer cells, but another theory is that the HDACi cause cancer cells to apoptose or differentiate. None of these mechanisms would seem to be something that would enhance iPS formation. 

Welcome
By Stem Cell Blogger | March 05, 2010 at 03:16 PM EST | 2 comments

Hi,

Welcome to the Chromatin Blog. I am a Stem and Chromatin researcher who is interested in providing a forum for discussions about Chromatin including recent papers, theories, products, etc.

Paul